Genomtec Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Public

  • Employees
  • 20

Employees

  • Stock Symbol
  • GMT

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.65
  • (As of Friday Closing)

Genomtec General Information

Description

Genomtec SA is an technology company which works in the area of molecular diagnostics. It is a manufacturer of mobile molecular analyzers. The device are designed to identify pathogens including viruses, bacteria, and fungi by amplifying and detecting specific DNA and RNA fragments.

Contact Information

Website
www.genomtec.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Wroclaw Business Park 3
  • Ulica Bierutowska Street 57-59
  • Wroclaw, 51-317
  • Poland
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Stock Exchange
WAR
Vertical(s)
Manufacturing, HealthTech, Life Sciences
Corporate Office
  • Wroclaw Business Park 3
  • Ulica Bierutowska Street 57-59
  • Wroclaw, 51-317
  • Poland

Genomtec Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genomtec Stock Performance

As of 13-Nov-2026, Genomtec’s stock price is $0.65. Its current market cap is $11.1M with 17.1M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.65 $0.69 $0.60 - $1.89 $11.1M 17.1M 27.1K -$0.14

Genomtec Financials Summary

As of 30-Jun-2026, Genomtec has a trailing 12-month revenue of $10.2K.

In Thousands,
USD 		TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 17,764 14,455 24,790 31,457
Revenue 10 6 1 1
EBITDA (1,457) (1,987) (2,208) (1,860)
Net Income (2,235) (2,772) (2,813) (2,144)
Total Assets 5,609 4,266 4,143 4,002
Total Debt 439 527 665 498
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Genomtec Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Genomtec‘s full profile, request access.

Request a free trial

Genomtec Patents

  • 92

    Total Documents Applications and Grants

  • Total Patents Families

  • 38

    Granted

  • 34

    Pending

  • Expiring in next 12 mo

Genomtec Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-2704594-A A method for detecting nucleotide variants in a nucleic acid sequence Pending 27-Jan-2025
WO-2026159365-A1 A method for detecting nucleotide variants in a nucleic acid sequence Pending 27-Jan-2025
GB-202501167-D0 A method for detecting nucleotide varients in a nucleic acid sequence Pending 27-Jan-2025
EP-4784796-A1 A method for detecting changes in nucleotide sequence changes using an isothermal nucleic acid amplification technology, a set of primers and a composition of a reaction mixture for the detection of selected genetic variants Pending 27-Sep-2023
WO-2025071422-A1 A method for detecting changes in nucleotide sequence changes using an isothermal nucleic acid amplification technology, a set of primers and a composition of a reaction mixture for the detection of selected genetic variants Inactive 27-Sep-2023 C12Q1/6858
To view Genomtec’s complete patent history, request access »

Genomtec Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genomtec Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Genomtec‘s full profile, request access.

Request a free trial

Genomtec Acquisitions (1)

Genomtec’s most recent deal was a Merger/Acquisition with ForLab. The deal was made on 27-Jun-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
ForLab 27-Jun-2022 Merger/Acquisition Distributors (Healthcare)
To view Genomtec’s complete acquisitions history, request access »

Genomtec ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Genomtec’s complete esg history, request access »

Genomtec FAQs

  • When was Genomtec founded?

    Genomtec was founded in 2016.

  • Where is Genomtec headquartered?

    Genomtec is headquartered in Wroclaw, Poland.

  • What is the size of Genomtec?

    Genomtec has 20 total employees.

  • What industry is Genomtec in?

    Genomtec’s primary industry is Diagnostic Equipment.

  • Is Genomtec a private or public company?

    Genomtec is a Public company.

  • What is Genomtec’s stock symbol?

    The ticker symbol for Genomtec is GMT.

  • What is the current stock price of Genomtec?

    As of 13-Nov-2026 the stock price of Genomtec is $0.65.

  • What is the current market cap of Genomtec?

    The current market capitalization of Genomtec is $11.1M.

  • What is Genomtec’s current revenue?

    The trailing twelve month revenue for Genomtec is $10.2K.

  • What is Genomtec’s annual earnings per share (EPS)?

    Genomtec’s EPS for 12 months was -$0.14.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process